Skip to main content
SpringerLink
Log in

Welche Patienten benötigen eine adjuvante systemische Polychemotherapie nach radikaler Zystektomie?

  • Kontroversen in der Uro-Onkologie
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Freiha F, Reese J, Torti F (1996) A randomized trial of radical cystectomy vs. radical castectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155: 495–500

    Article  CAS  PubMed  Google Scholar 

  2. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MRS, Clarkson B, Oettgen HF, Alton K, Weite K, Souza L (1989) Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional carcinoma of the urothelium. N Engl J Med 318: 1414–1422

    Article  Google Scholar 

  3. Gschwend J, Vieweg J, Herr HW, Fair WR (1997) Krankheitsspezifisches Überleben nach radikaler Zystektomie beim Blasenkarzinom —10 Jahre Erfahrung und Langzeit-Nachbeobachtung. Urologe [A] [Suppl] 1: 5

    Google Scholar 

  4. Herr HW (1989) Neoadjuvant chemotherapy for invasiv bladder cancer. Semin Surg Oncol 5: 266–271

    Article  CAS  PubMed  Google Scholar 

  5. Igawa M, Ohkuchi T, Ueki T, Ueda M, Okada K, Usui T (1990) Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer. J Urol 144: 662–665

    CAS  PubMed  Google Scholar 

  6. Loehrer PJ, Einhorn LH, Elson PJ, Crawford ED, Kuebler P, Tannock I, Raghavan D, Stuart-Harris R, Sarosdy MF, Lowe BA, Blumenstein B, Trump D (1992) A randomized comparison of Cisplatin alone or in combination with Methotrexate, Vinblastine and doxorubicin in a cooperative group study. J Clin Oncol 10: 1066–1073

    PubMed  Google Scholar 

  7. Logothetis JC, Johnson DE, Cong C (1988) Adjuvant cyclophosphamide, doxorubicin and cisplatin chemotherapy for bladder cancer, an update. J Clin Oncol 6: 1590

    CAS  PubMed  Google Scholar 

  8. Logothetis JC, Dexeus FH, Fin L, Sella A, Amato RJ, Ayala AG, Kilbourn RG (1990) A prospective randomiced trial comparing M-VAC and CisCA chemotherapy for patients with metastatic urothelial tumours. J Clin Oncol 8: 1050–1055

    CAS  PubMed  Google Scholar 

  9. Miller K (F1994) Operative Therapie des invasiven Harnblasenkarzinoms. In: Otto T, Bach F (Hrsg) Aktuelle Diagnostik und Therapie des Harnblasenkarzinoms. Zuckschwerdt, München

  10. Miller RS, Freiha FS, Reese JH, Ozen H, Torti FM (1993) Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. J Urol 150: 65–69

    CAS  PubMed  Google Scholar 

  11. Roehrborn CG, Sagalowsky AI, Peters PC (1991) Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder. J Urol 146: 36–39

    CAS  PubMed  Google Scholar 

  12. Rübben H, Otto T (1997) Harnblasenkarzinom. In: Rübben H (Hrsg) Uro-Onkologie. Springer, Berlin Heidelberg New York

    Google Scholar 

  13. Scher HI, Yagoda A, Herr HW, Sternberg CN, Bosl G, Morse MJ, Sogani PC, Watson RC, Dershaw DD, Reuter V (1988) Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion. J Urol 139: 470–474

    CAS  PubMed  Google Scholar 

  14. Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128: 34–36

    CAS  PubMed  Google Scholar 

  15. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, Kern W, Sakamoto J, Krailo M, Groshen S (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145: 459–464

    CAS  PubMed  Google Scholar 

  16. Smith JA, Whitmore WF Jr (1981) Regional lymph node metastases from bladder cancer. J Urol 126: 591–593

    PubMed  Google Scholar 

  17. Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Weiselberg LR (1988) M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for adjuvant transitional cell carcinoma of the urothelium. J Urol 139: 461–469

    CAS  PubMed  Google Scholar 

  18. Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thuroff JW, Huber C, Hohenfellner R (1991) Fortgeschrittenes Blasenkarzinom (Stadien pT3 b, pT4a, pN1, pN2). Verbesserte Überlebensraten nach radikaler Zystektomie durch 3 adjuvante Zyklen M-VAC/M-VEC —Erste Erfahrungen einer kontrollierten prospektiven Studie. Akt Urol 22: 201

    Article  Google Scholar 

  19. Stöckle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Jhüroff JW, Huber C, Hohenfellner R (1992) Advanced bladder cancer (stages pT3 b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148: 302–307

    PubMed  Google Scholar 

  20. Stöckle M (1994) Adjuvante Polychemotherapie nach radikaler Zystektomie bei organüberschreitendem Harnblasenkarzinom. Urologe [A] 33: 568–575

    Google Scholar 

  21. Studer UE, Wallace DMA, Ruchti E, Zingg RJ (1985) The role of pelvic lymph node metastases in bladder cancer. World J Urol 3: 98–103

    Article  Google Scholar 

  22. Trasher JB, Crawford ED (1993) Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 149: 957–972

    Google Scholar 

  23. Whitmore WF (1983) Management of invasive bladder neoplasms. Semin Urol 1: 4–10

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik, Medizinische Universität Lübeck, Ratzeburger Allee 160, D-23538, Lübeck

    J. Sandmann &  A. Böhle

Authors
  1. J. Sandmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Böhle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sandmann, J., Böhle, A. Welche Patienten benötigen eine adjuvante systemische Polychemotherapie nach radikaler Zystektomie?. Der Urologe B 38, S10–S13 (1998). https://doi.org/10.1007/BF03351086

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351086

Search

Navigation